Skip to content

LivaNova LIVN Total Equity

Total Equity at other companies

Abbott logo
AbbottABT
$52.06B+6.7%
Haemonetics logo
HaemoneticsHAE
$796.32M-3.0%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
ResMed logo
ResMedRMD
$6.49B+17.1%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.63B+13.9%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's total equity?
LivaNova (LIVN) reported total equity of $1.21B in Q1 2026.
How has LivaNova's total equity changed year-over-year?
LivaNova's total equity increased by 17.1% year-over-year, from $1.03B to $1.21B.
What is the long-term trend for LivaNova's total equity?
Over 5 years (2020 to 2025), LivaNova's total equity has grown at a 1.6% compound annual growth rate (CAGR), from $1.11B to $1.2B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.